HOMA-IR, triglycerides, total cholesterol, HDL and LDL did not differ between the groups. CONCLUSION: Lactation has a beneficial effect on maternal long term weight, adiposity and some markers of metabolic syndrome such as fasting glucose. Moreover, our results suggest a role for oxytocin in mediating these benefits.
1006 Variation in late pregnancy total blood volume: implications for blood loss quantification in postpartum hemorrhage
Kelley McLean, Jessica Parson, Ira Bernstein
University of Vermont, Burlington, VT OBJECTIVE: Quantification of blood loss (using calibrated drapes and/ or weighing of clots and blood soaked materials) has been touted as a means to improve the recognition and treatment of postpartum hemorrhage (PPH). However, the maternal physiologic response to blood loss depends on total blood volume (TBV) prior to delivery, and the clinical significance of quantified blood loss (QBL) will depend in part upon the degree of blood volume expansion in pregnancy (where TBV ¼ plasma volume + red cell volume). Prior small studies have demonstrated significant variation in late pregnancy TBV in varied clinical contexts. The purpose of this study was to assess the variation of TBV expansion in a cohort of women at risk for preeclampsia. STUDY DESIGN: TBV was calculated from longitudinal measurements of PV prior to conception (follicular phase) and in late pregnancy (32-36 weeks) in a cohort of women at risk for preeclampsia due to nulliparous status or prior preeclampsia. TBV was calculated for all women by direct measurement of PV using Evan's blue dye injection, and hematocrit. The hematocrit was corrected using a generally accepted "whole body/peripheral hematocrit ratio" of 0.9. Thus, TBV ¼ Plasma Volume/(1-{hematocrit x 0.9}). RESULTS: Figure 1 shows the median and range of PV expansion from pre-conception to late pregnancy in women who were normotensive at delivery (n¼52), and in those who developed hypertensive disorders (preterm preeclampsia {n¼7}, term preeclampsia {n¼5}, gestational hypertension {n¼10}). PV expansion in the entire cohort ranged from -1% to 97%, with an overall median of 52%. Figure 2 demonstrates the median and range of total PV and TBV in late pregnancy for each group. Third trimester total PV and TBV ranged from 2380ml to 6050ml (median ¼ 3796ml), and from 3852ml to 8391ml (median 5476ml), respectively, in the entire cohort. CONCLUSION: Late pregnancy TBV (largely driven by PV expansion), is higher in normal pregnancies than in those complicated by hypertensive disorders, though there is substantial individual variation across all groups. The maternal physiologic response to a given volume of blood loss will be unpredictable as a result of such variation. Thus, despite frequent focus on blood loss quantification methods (QBL) as a means to improve maternal care, the maternal physiologic response-not the specific volume of blood lost, is likely to be most crucial in the timely recognition and management of PPH. 1 H magnetic resonance spectroscopy to assess IHL and IMCL content; MRI to assess subcutaneous abdominal lipids (SAT), and BODPOD to assess fat mass (FM). Fetal abdominal circumference (AC) was used as a proxy for fetal abdominal adiposity and was assessed by ultrasound. Birth date and newborn weight, length, and sex were abstracted from delivery records to calculate weight for gestational age at birth (WGA) and ponderal index (PI, [weight (kg)/length 3 (m 3 )]). We used Pearson correlation and regression to assess the relationship of maternal ectopic lipid stores with measures of insulin sensitivity and neonatal size. RESULTS: Participants were primarily White (84%) with mean age of 31 (19-39) years and BMI of 26 (18-36) kg/m 2 . Two had preterm births (<37 weeks GA). Maternal ectopic lipid stores were not significantly correlated with newborn size or fetal AC; whereas, maternal total fat mass and SAT were positively correlated with fetal AC (Table 1) . EGP was positively correlated with newborn weight, WGA, and fetal AC. EGP was also positively correlated with maternal weight, FM, BMI, and SAT but was not significantly correlated with IHL or IMCL (Table 2) . EGP remained positively associated with newborn size and fetal AC after adjusting for IHL and IMCL. CONCLUSION: Increasing EGP (decreasing hepatic insulin sensitivity) was associated with increasing newborn size and fetal AC independent of maternal hepatic and skeletal muscle lipid stores. We did not find an association between maternal ectopic lipid stores and neonatal size.
Progesterone accelerates wound healing in human amniotic epithelial cells through mesenchymal to epithelial transition
Lauren Richardson, George R. Saade, Ramkumar Menon
The University of Texas Medical Branch, Galveston, TX OBJECTIVE: Progesterone (P4) maintains pregnancy by upholding myometrial quiescence and regulating cervical matrix remodeling. However, its function in maintaining fetal membrane homeostasis is unclear. Similarly, nurturing properties of amniotic fluid (AF) on amnion membrane cells remodeling without rupture during normal gestation is also unclear. Using an in vitro model of human amnion epithelial cell (AEC) wound healing, wWe determined that both P4 and AF accelerate wound healing properties of AECs that will maintain membrane integrity during fetal growth and development. STUDY DESIGN: Scratch assays were performed on primary AECs derived from normal term not in labor membranes grown in following conditions or exposures: 1) normal cell culture conditions (control), 2) oxidative stress (OS) induction by cigarette smoke extract (CSE) to mimic uterine conditions at term labor, 3) term not in labor AF, and 4) P4 30ng/mL. Cellular changes associated with wound healing were determined by localizing intermediate filament (cytokeratin (CK)-18 and vimentin) by immunohistochemistry. Ttest showed significance (p<0.05). RESULTS: Proliferation, migration and transition of AECs in normal culture conditions healed the wound (scratch) within 38 hrs. AF and P4 treatments expedited wound healing while OS prevented wound closure (Fig. 1A-B) . Vimentin/CK-18 ratio changes suggest that cellular transitions, epithelial to mesenchymal transition (EMT) propel cell migration whereas reversal of this process, mesenchymal to epithelial transitions (MET), seals the wound. OS prevented wound closure by inducing a static state of EMT while AF and P4 accelerated MET and cellular homeostasis (Fig. 1C) (Fig. 2) . CONCLUSION: AF and P4 remodel can fetal membranes by recycling of cells through transitions. Mesenchymal cells in the extracellular matrix are likely cell reservoirs that are transitioned by Af or P4 to fill epithelial gaps created by cell shedding during fetal/membrane growth. Uterine conditions at term or preterm averts this transition to cause membrane weakening and rupture.
